Michael Kishko

8PUBLICATIONS
24CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthAnimal protection (incl. pests and pathogens)Agricultural molecular engineering of nucleic acids and proteinsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 28, 2025
Epitope Profiling of SARS-CoV-2 Spike Antigen Provides a Novel Strategy for Developing ELISAs Specific for Different Spike Protein Variants in Bivalent Vaccine Formulations.

Luciano Ettorre, Trevor Williams, Camille Houy

|Apr 09, 2024
Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein.

Judith Alamares-Sapuay, Michael Kishko, Charles Lai

|May 26, 2023
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters.

Catherine Berry, Vincent Pavot, Natalie G Anosova

|Mar 09, 2023
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates.

Vincent Pavot, Catherine Berry, Michael Kishko

|Jun 30, 2022
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle.

Jennifer N Rainho-Tomko, Vincent Pavot, Michael Kishko

|Apr 01, 2022
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates.

Vincent Pavot, Catherine Berry, Michael Kishko

Pageof 2

Frequent Collaborators

3 joint publications

Marguerite Koutsoukos

3 joint publications

Vincent Pavot

3 joint publications

Valerie Lecouturier

3 joint publications

Catherine Berry